Inspira™ receives first ever u.s. patent approval for an orbiting blood oxygenation delivery system

94% of the claims were found to be novel ra'anana, israel , feb. 14, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira technologies"), is a breakthrough medical technology company targeting to supersede mechanical ventilators, has received the first ever u.s. patent approval for an orbiting blood oxygenation delivery system, a core technology of the revolutionary inspira™ art500 device.
IINN Ratings Summary
IINN Quant Ranking